These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 17545609
1. Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Qiao M, Iglehart JD, Pardee AB. Cancer Res; 2007 Jun 01; 67(11):5293-9. PubMed ID: 17545609 [Abstract] [Full Text] [Related]
5. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer. Shi YY, Small GW, Orlowski RZ. Breast Cancer Res Treat; 2006 Nov 01; 100(1):33-47. PubMed ID: 16807678 [Abstract] [Full Text] [Related]
9. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase. Tan M, Grijalva R, Yu D. Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638 [Abstract] [Full Text] [Related]
10. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Park SS, Kim SW. Oncol Rep; 2007 Jul 01; 18(1):139-43. PubMed ID: 17549359 [Abstract] [Full Text] [Related]
12. Raptor-rictor axis in TGFbeta-induced protein synthesis. Das F, Ghosh-Choudhury N, Mahimainathan L, Venkatesan B, Feliers D, Riley DJ, Kasinath BS, Choudhury GG. Cell Signal; 2008 Feb 01; 20(2):409-23. PubMed ID: 18068336 [Abstract] [Full Text] [Related]
13. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. Pan MH, Lin CC, Lin JK, Chen WJ. J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658 [Abstract] [Full Text] [Related]
14. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells. Manuvakhova M, Thottassery JV, Hays S, Qu Z, Rentz SS, Westbrook L, Kern FG. Oncogene; 2006 Sep 28; 25(44):6003-14. PubMed ID: 16682955 [Abstract] [Full Text] [Related]
15. Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity. Varma S, Shrivastav A, Changela S, Khandelwal RL. Exp Cell Res; 2008 Apr 01; 314(6):1281-91. PubMed ID: 18261725 [Abstract] [Full Text] [Related]
17. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Xu W, Yuan X, Jung YJ, Yang Y, Basso A, Rosen N, Chung EJ, Trepel J, Neckers L. Cancer Res; 2003 Nov 15; 63(22):7777-84. PubMed ID: 14633703 [Abstract] [Full Text] [Related]
18. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol. Kunz C, Borghouts C, Buerger C, Groner B. Mol Cancer Res; 2006 Dec 15; 4(12):983-98. PubMed ID: 17189388 [Abstract] [Full Text] [Related]